|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
14.130 +0.340 (+2.466%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,211,796 | 1,086,987 | 818,973 | 947,679 |
| Net Cash from / (used in) Investing Activities | -- | (2,153,114) | (186,910) | (231,772) | (368,804) |
| Net Cash from / (used in) Financing Activities | -- | (711,739) | (729,258) | (280,100) | (342,205) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,653,057) | 170,819 | 307,101 | 236,670 |
| Cash & Cash Equivalents at beginning of period | -- | 2,907,682 | 2,748,262 | 2,450,173 | 2,196,323 |
| Effect of Foreign Exchange Rate Changes | -- | (20,241) | (11,399) | (9,012) | 17,180 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,234,384 | 2,907,682 | 2,748,262 | 2,450,173 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 595,309 |
| %Change | 19.468% |
| EPS / (LPS) | RMB 0.710 |
| NBV Per Share (¥) | RMB 5.674 |